AstraZeneca consolidates its drug development work

03/19/2013 | Reuters · USA Today

AstraZeneca plans to restructure its research and development operations to bring together drug development activities in three major facilities in the U.S., England and Sweden. A Gaithersburg, Md., facility will become the main hub for biotech research. The changes, meant to cut costs and increase productivity, will eliminate about 1,600 positions.

View Full Article in:

Reuters · USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC